Guidelines for reporting mortality and morbidity after cardiac valve interventions

article

Guidelines for reporting mortality and morbidity after cardiac valve interventions is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JTCVS.2007.12.002
P698PubMed publication ID18374749

P50authorSociety of Thoracic SurgeonsQ7552666
Johanna TakkenbergQ40276710
David M ShahianQ92508908
Eugene H BlackstoneQ96650503
P2093author name stringDavid H Adams
Tirone E David
John E Mayer
Bruce W Lytle
D Craig Miller
Marko I Turina
Gary L Grunkemeier
Nicholas T Kouchoukos
Siegfried Hagl
Eric G Butchart
Cary W Akins
Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity
Councils of the American Association for Thoracic Surgery
European Assoication for Cardio-Thoracic Surgery
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)732-738
P577publication date2008-04-01
P1433published inThe Journal of Thoracic and Cardiovascular SurgeryQ2795598
P1476titleGuidelines for reporting mortality and morbidity after cardiac valve interventions
P478volume135

Reverse relations

cites work (P2860)
Q4804931810-year results of On-X bileaflet mechanical heart valve in the aortic position: low target INR regimen in Japanese
Q53603164A simple way to treat mitral valve prolapse: chordal replacement using a new mitral leaflet retractor.
Q50936947Aortic cusp sizers to establish the functional classification of aortic insufficiency: algorithm and midterm outcome of operative repair.
Q38816832Aortic valve repair in the paediatric population: insights from a 38-year single-centre experience
Q44996459Autograft and pulmonary allograft performance in the second post-operative decade after the Ross procedure: insights from the Rotterdam Prospective Cohort Study
Q96123049Bioprosthetic vs mechanical mitral valve replacement for infective endocarditis in patients aged 50 to 69 years
Q36713947Cerebrovascular Events After No-Touch Off-Pump Coronary Artery Bypass Grafting, Conventional Side-Clamp Off-Pump Coronary Artery Bypass, and Proximal Anastomotic Devices: A Meta-Analysis
Q37531970Choice of Aortic Valve Prosthesis in a Rapidly Aging and Long-Living Society
Q37073658Chordal Reconstruction versus Leaflet Resection for Repair of Degenerative Posterior Mitral Leaflet Prolapse
Q40657128Clinical and haemodynamic outcomes in 658 patients receiving the Perceval sutureless aortic valve: early results from a prospective European multicentre study (the Cavalier Trial)†.
Q53595006Clinical and hemodynamic study of tilting disc heart valve: Single-center study.
Q53606138Clinical efficacy of transcatheter aortic valve replacement for severe aortic stenosis in high-risk patients: the PREVAIL JAPAN trial.
Q92619307Clinical outcome and hemodynamic performance of St. Jude Trifecta aortic prosthesis: short-term follow-up and risk factors analysis
Q92476096Comparison of quality of life in patients who underwent mechanical mitral valve replacement: star GK vs SJM
Q44197054David valve-sparing aortic root replacement: equivalent mid-term outcome for different valve types with or without connective tissue disorder.
Q37378755De Vega annuloplasty for functional tricupsid regurgitation: concept of tricuspid valve orifice index to optimize tricuspid valve annular reduction
Q37021109Decellularized aortic homografts for aortic valve and aorta ascendens replacement
Q37110759Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience
Q37876678Diagnostic evaluation of left-sided prosthetic heart valve dysfunction
Q38254529Did you write a protocol before starting your project?
Q39914133Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients
Q49985108Early Clinical Experience with Sutureless Aortic Valve Replacement for Severe Aortic Stenosis
Q47207800Early and late outcomes after open ascending aortic surgery: 47-year experience in a single centre.
Q41337431Early and late outcomes of complex aortic root surgery in patients with aortic root abscesses.
Q49617416Early and late results of surgical treatment for isolated active native mitral valve infective endocarditis
Q50014734Early and long-term outcomes of mitral valve repair for Barlow's disease: a single-centre 16-year experience
Q53590157Early prosthetic valve degeneration with Mitroflow aortic valves: determination of incidence and risk factors†.
Q39045521Effect of bioprostheses anti-calcification treatment: comparative follow-up between Mitroflow LX and Magna pericardial xenografts using a propensity score-weighted analysis
Q42108258Evaluating operative mortality of cardiac surgery: first define operative mortality
Q37179552Flexible band versus rigid ring annuloplasty for functional tricuspid regurgitation: two different patterns of right heart reverse remodelling
Q84604596Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation
Q40334003Impact of failed mitral valve repair on hospital outcome of redo mitral valve procedures.
Q38116944Improved long-term survival for rheumatic mitral valve repair compared to replacement in the young
Q36944832Individualized thoracic aortic replacement for the aortopathy of biscuspid aortic valve disease
Q37200743International Expert Consensus on Sutureless and Rapid Deployment Valves in Aortic Valve Replacement Using Minimally Invasive Approaches
Q64914262Late clinical outcomes after mechanical aortic valve replacement for aortic stenosis: old versus new prostheses.
Q53503803Late haemodynamic performance and survival after aortic valve replacement with the Mosaic bioprosthesis.
Q60044458Late thrombosis of a Transcatheter aortic valve: the border between a proactive and reactive management
Q85046158Leaflet suspension to the contralateral annulus to address restriction or tethering-induced mitral and tricuspid regurgitation in children: results of a case-control study
Q35640227Long-Term Outcome of Prosthetic Valve Replacement in Japanese Patients Aged 65 Years or Older: Are Guidelines for Prosthetic Valve Selection Based on Overseas Data Appropriate for Japanese Patients?
Q40845408Long-Term Outcomes and Durability of the Mitroflow Aortic Bioprosthesis.
Q64265889Long-Term Results of the Leaflet Extension Technique for Rheumatic Aortic Regurgitation: A 20-Year Follow-up
Q39733442Long-term follow-up after aortic root replacement with the Shelhigh® biological valved conduit: a word of caution!
Q40156256Long-term follow-up after implantation of the Shelhigh® No-React® complete biological aortic valved conduit
Q51549040Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial.
Q49609921Long-term results of annuloplasty in trivial-to-mild functional tricuspid regurgitation during mitral valve replacement: should we perform annuloplasty on the tricuspid valve or leave it alone?
Q53613745Long-term results of the Ross operation: an 18-year single institutional experience.
Q48751475Longitudinal strain predicts left ventricular mass regression after aortic valve replacement for severe aortic stenosis and preserved left ventricular function
Q48679193Low target-INR anticoagulation is safe in selected aortic valve patients with the Medtronic Open Pivot mechanical prosthesis: long-term results of a propensity-matched comparison with standard anticoagulation
Q50089781Mechanical aortic valve replacement in non-elderly adults: meta-analysis and microsimulation
Q51137223Mid-term results of 17-mm St. Jude Medical Regent prosthetic valves in elder patients with small aortic annuli: comparison with 19-mm bioprosthetic valves.
Q49549083Mitral valve repair in Barlow's disease with bileaflet prolapse: the effect of annular stabilization on functional mitral valve leaflet prolapse
Q34420256Morbidity and mortality of nonagenarians undergoing CoreValve implantation.
Q88059819More than 20-year experience of Bentall operation with mechanical prostheses for chronic aortic root aneurysm
Q91766497New warfarin anticoagulation management model after heart valve surgery: rationale and design of a prospective, multicentre, randomised trial to compare an internet-based warfarin anticoagulation management model with the traditional warfarin manage
Q92340665Nineteen Years of Single Institute Experiences with Sorin Bicarbon Prosthesis
Q36251879Outcome following valve surgery in Australia: development of an enhanced database module
Q38187580Outcome of surgical management for active mitral native valve infective endocarditis: a collective review of 57 patients
Q50027405Outcomes comparison of different surgical strategies for the management of severe aortic valve stenosis: study protocol of a prospective multicentre European registry (E-AVR registry).
Q40657789Over 20 years experience with aortic homograft in aortic valve replacement during acute infective endocarditis
Q40374053Porcine xenograft for aortic, mitral and double valve replacement: long-term results of 2544 consecutive patients
Q35942124Preexisting heart failure is an underestimated risk factor in cardiac surgery
Q39272847Prosthetic heart valves
Q36227299Prosthetic valves in adult patients with congenital heart disease: Rationale and design of the Dutch PROSTAVA study
Q37597824Pulmonary autograft in aortic position: is everything known?
Q92692533Reinterventions after freestyle stentless aortic valve replacement: an assessment of procedural risks
Q47330351Repair versus replacement for the surgical correction of tricuspid regurgitation: a meta-analysis
Q42677819Results of mitral valve repair for Barlow disease (bileaflet prolapse) via right minithoracotomy versus conventional median sternotomy: A randomized trial
Q51067534Results of mitral valve repair with an adjustable annuloplasty ring 2 years after implantation.
Q37067786Results of proximal arch replacement using deep hypothermia for circulatory arrest: is moderate hypothermia really justifiable?
Q92775349Risk factors and clinical significance of elevated mitral valve gradient following valve repair for degenerative disease
Q83393600Role of echocardiogram in decision making for surgery in endocarditis
Q36304184St. Jude Medical Trifecta aortic valve: results from a prospective regional multicentre registry
Q37194219St. Jude Medical Trifecta™ aortic valve perioperative performance in 200 patients
Q50094191Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular In
Q50220521Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular In
Q34492675Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium
Q47681750Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint
Q57629463Standards defining a ‘Heart Valve Centre’: ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint
Q38271186Starting minimally invasive valve surgery using endoclamp technology: safety and results of a starting surgeon.
Q99631909Stentless Root Replacement versus Tissue Valves in Infective Endocarditis - A Propensity-Score Matched Study
Q36803307Stentless aortic valve replacement in the young patient: long-term results
Q85013716Stentless biological valved conduit for aortic root replacement: Initial experience with the Shelhigh BioConduit model NR-2000C
Q40823788Stentless bioprostheses: a versatile and durable solution in extensive aortic valve endocarditis
Q36365991Subsequently occurring bilateral iliopsoas hematoma: a case report
Q55249855Surgical Treatment of Annuloaortic Ectasia - Replace or Repair?
Q40875192Surgical ablation of atrial fibrillation in patients with a giant left atrium undergoing mitral valve surgery
Q38543625Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease.
Q39914127Surgical factors and complications affecting hospital outcome in redo mitral surgery: insights from a multicentre experience
Q37714696Surgical treatment of infective endocarditis in active intravenous drug users: a justified procedure?
Q30316000Sutureless, rapid deployment valves and stented bioprosthesis in aortic valve replacement: recommendations of an International Expert Consensus Panel.
Q58570784Ten-year experience of tricuspid valve replacement with the St. Jude medical valve
Q38826615Ten-year results of aortic valve replacement with first-generation Mitroflow bioprosthesis: is early degeneration a structural or a technical issue?
Q48054543Ten-year results of the Freedom Solo stentless heart valve: excellent haemodynamics but progressive valve dysfunction in the long term
Q93029889The AVIATOR registry: the importance of evaluating long-term patient outcomes
Q38729903The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue†.
Q36736461The Mosaic Mitral Valve Bioprosthesis: A Long-Term Clinical and Hemodynamic Follow-Up
Q37800577The Society of Thoracic Surgeons National Adult Cardiac Database: A continuing commitment to excellence
Q28073317The echocardiography of replacement heart valves
Q37722026The effects of 21 and 23 milimeter aortic valve prosthesis on hemodynamic performance and functional capacity in young adults
Q51190768The fate of pulmonary conduits after the Ross procedure: longitudinal analysis of the German-Dutch Ross registry experience.
Q38771029The flaws in the detail of an observational study on transcatheter aortic valve implantation versus surgical aortic valve replacement in intermediate-risks patients.
Q37507409The long-term results and changing patterns of biological valves at the mitral position in contemporary practice in Japan
Q45001745The role of annular dimension and annuloplasty in tricuspid aortic valve repair
Q40818317Three-year haemodynamic performance of the St Jude Trifecta bioprosthesis.
Q48080483Three-year results of repaired Barlow mitral valves via right minithoracotomy versus median sternotomy in a randomized trial
Q90455769Timing of pulmonary valve replacement in patients with corrected Fallot to prevent QRS prolongation
Q34144699Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
Q84530692Twelve years of experience with the ATS mechanical heart valve prostheses
Q84010950Twelve-year experience with the Carpentier-Edwards pericardial aortic valve at a single Japanese center
Q50084270Twenty-year experience with stentless biological aortic valve and root replacement: informing patients of risks and benefits
Q57629487Valve Cuspidity: A Risk Factor for Aortic Valve Repair?
Q44445500Valvular heart surgery: evaluating the past to enlighten the future

Search more.